Tiotropium bromide is a long-acting inhaled medication that opens the airways and keeps them open for at least 24 hours, making it a once-daily maintenance treatment for chronic obstructive pulmonary disease (COPD) and, in some formulations, asthma. Sold under the brand name Spiriva, it belongs to a class of drugs called anticholinergics (also called antimuscarinics), which work by blocking nerve signals that cause airway muscles to tighten.
How Tiotropium Works
Your airways are lined with smooth muscle that can contract or relax in response to signals from the nervous system. A chemical messenger called acetylcholine binds to specific receptors on that muscle and triggers it to squeeze, narrowing the airway. Tiotropium blocks those receptors so acetylcholine can’t activate them, allowing the muscles to stay relaxed and the airways to remain wide.
What makes tiotropium different from older, shorter-acting inhalers in the same class is how stubbornly it clings to its targets. It binds to three receptor subtypes (M1, M2, and M3), but it separates very slowly from the M1 and M3 receptors, which are the ones most responsible for airway constriction. That slow release is the reason a single dose keeps working for a full day or longer, protecting against airway tightening for more than 24 hours. Older anticholinergic inhalers like ipratropium wear off in 6 to 8 hours and need to be used multiple times a day.
What It Treats
Tiotropium is primarily prescribed as a daily maintenance treatment for COPD, which includes chronic bronchitis and emphysema. It is not a rescue inhaler and won’t relieve a sudden flare of breathlessness. Instead, it works in the background to keep airways open day after day, reducing symptoms like chronic cough, wheezing, and shortness of breath over time.
Certain formulations of tiotropium (specifically the Respimat soft mist inhaler) are also approved for long-term asthma management in people whose symptoms aren’t adequately controlled by inhaled corticosteroids alone. In both COPD and asthma, it is an add-on therapy, meaning it’s used alongside other medications rather than replacing them.
Reducing COPD Flare-Ups
Beyond day-to-day symptom control, one of tiotropium’s most important benefits is its effect on exacerbations, the sudden worsening episodes that send many people with COPD to the emergency room. A comprehensive systematic review found that tiotropium extends the time before a first exacerbation occurs and reduces the total number of flare-ups, including severe episodes that lead to hospitalization. This held true when tiotropium was compared to both placebo and other types of long-acting bronchodilators. For people with moderate to severe COPD, fewer exacerbations translates directly into better quality of life and slower disease progression.
Delivery Devices and Dosing
Tiotropium comes in two main delivery systems, and the dose depends on which one you use:
- HandiHaler: A dry powder inhaler that uses individual capsules. The standard dose is 18 micrograms of tiotropium, inhaled once daily. You place a capsule into the device, puncture it, and take two deep inhalations to get the full dose. The capsules are not meant to be swallowed.
- Respimat: A soft mist inhaler that turns liquid medication into a slow-moving mist. The COPD dose delivers 5 micrograms per day (two puffs of 2.5 micrograms each). Despite the lower number, pharmacokinetic testing shows the body absorbs a similar amount of drug from 5 mcg via Respimat and 18 mcg via HandiHaler, so the two are considered equivalent in terms of systemic exposure.
What to Expect After Starting
Tiotropium begins working within about 30 minutes of the first inhalation, with peak bronchodilation occurring 3 to 4 hours later. However, the full benefit builds over the first week or two of daily use, so initial improvement on day one doesn’t represent the medication’s ceiling. Because it lasts at least 24 hours, you take it at the same time each day, and missing or doubling doses can disrupt steady airway protection.
This is a controller medication, not something you reach for during an acute breathing emergency. You should still keep a fast-acting rescue inhaler available for sudden symptoms.
Common Side Effects
Because tiotropium blocks acetylcholine, its side effects tend to reflect reduced moisture and muscle activity in various tissues. Dry mouth is the most frequently reported side effect, and for most people it is mild. Upper respiratory tract infections, sore throat, and sinus irritation also occur. Constipation and urinary difficulty can happen, particularly in older adults or anyone already prone to those issues.
More serious reactions are uncommon but include worsening of narrow-angle glaucoma if the mist or powder contacts the eyes, and urinary retention in men with enlarged prostates. Allergic reactions, while rare, can occur in people with known sensitivity to tiotropium, ipratropium, or atropine.
Who Should Avoid It
Tiotropium is contraindicated for people with a known allergy to tiotropium itself, to ipratropium (a related inhaler), or to atropine, due to the risk of anaphylaxis. It is also contraindicated in narrow-angle glaucoma, a condition where pressure builds inside the eye, because anticholinergic drugs can worsen that pressure.
People with an enlarged prostate or bladder-neck obstruction should use tiotropium cautiously, since blocking acetylcholine can make it harder to empty the bladder. If you notice a weak urine stream or difficulty urinating after starting the medication, that warrants a prompt conversation with your prescriber about whether to continue.